Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Ratjen

Showing results (241-250 of 326) with videos related to

Pageof 33
Sort By:
Pediatric Research|October 13, 2010
Skeletal muscle metabolism in cystic fibrosis and primary ciliary dyskinesiaGreg D Wells, Donna L Wilkes, Jane E Schneiderman, et al.
Annals of the American Thoracic Society|July 10, 2020
Clinical Effectiveness of Lumacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for F508del-CFTR. A Clinical TrialScott D Sagel, Umer Khan, Sonya L Heltshe, et al.
The Lancet. Respiratory Medicine|March 14, 2022
The effect of inhaled hypertonic saline on lung structure in children aged 3-6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trialHarm A W M Tiddens, Yuxin Chen, Eleni-Rosalina Andrinopoulou, et al.
Plos One|June 16, 2016
A Systematic Approach to Multiple Breath Nitrogen Washout Test QualityRenee Jensen, Sanja Stanojevic, Michelle Klingel, et al.
Respiratory Medicine|April 22, 2026
Real-World Impact of Elexacaftor/Tezacaftor/Ivacaftor on Health-Related Quality of Life in Adults with Cystic Fibrosis: A 12-Month Multicenter Cohort StudyRazan Kharraz, Elizabeth Tullis, Jenna Sykes, et al.
Chest|November 15, 2025
Structural and Functional Pulmonary MRI to Predict Pulmonary Exacerbations in Cystic FibrosisAlexander M Matheson, Abdullah S Bdaiwi, Matthew M Willmering, et al.
JAMA|May 6, 2010
Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trialLisa Saiman, Michael Anstead, Nicole Mayer-Hamblett, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 17, 2014
Serology as a diagnostic tool for predicting initialPseudomonas aeruginosa acquisition in children with cystic fibrosisCori Daines, Donald VanDeVanter, Umer Khan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 5, 2019
Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practicesEdith Zemanick, Pierre-Régis Burgel, Giovanni Taccetti, et al.
Pediatric Pulmonology|February 3, 2015
Novel outcome measures for clinical trials in cystic fibrosisHarm A W M Tiddens, Michael Puderbach, Jose G Venegas, et al.
Pageof 33

Showing results (241-250 of 326) with videos related to

Sort By:
Pageof 33
Pediatric Research|October 13, 2010
Skeletal muscle metabolism in cystic fibrosis and primary ciliary dyskinesiaGreg D Wells, Donna L Wilkes, Jane E Schneiderman, et al.
Annals of the American Thoracic Society|July 10, 2020
Clinical Effectiveness of Lumacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for F508del-CFTR. A Clinical TrialScott D Sagel, Umer Khan, Sonya L Heltshe, et al.
The Lancet. Respiratory Medicine|March 14, 2022
The effect of inhaled hypertonic saline on lung structure in children aged 3-6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trialHarm A W M Tiddens, Yuxin Chen, Eleni-Rosalina Andrinopoulou, et al.
Plos One|June 16, 2016
A Systematic Approach to Multiple Breath Nitrogen Washout Test QualityRenee Jensen, Sanja Stanojevic, Michelle Klingel, et al.
Respiratory Medicine|April 22, 2026
Real-World Impact of Elexacaftor/Tezacaftor/Ivacaftor on Health-Related Quality of Life in Adults with Cystic Fibrosis: A 12-Month Multicenter Cohort StudyRazan Kharraz, Elizabeth Tullis, Jenna Sykes, et al.
Chest|November 15, 2025
Structural and Functional Pulmonary MRI to Predict Pulmonary Exacerbations in Cystic FibrosisAlexander M Matheson, Abdullah S Bdaiwi, Matthew M Willmering, et al.
JAMA|May 6, 2010
Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trialLisa Saiman, Michael Anstead, Nicole Mayer-Hamblett, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 17, 2014
Serology as a diagnostic tool for predicting initialPseudomonas aeruginosa acquisition in children with cystic fibrosisCori Daines, Donald VanDeVanter, Umer Khan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 5, 2019
Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practicesEdith Zemanick, Pierre-Régis Burgel, Giovanni Taccetti, et al.
Pediatric Pulmonology|February 3, 2015
Novel outcome measures for clinical trials in cystic fibrosisHarm A W M Tiddens, Michael Puderbach, Jose G Venegas, et al.
Pageof 33